Source: This report is based on the article “When Will Genetically Modifying Our Children Go Mainstream?” by Ed Cara, originally published by Gizmodo on June 22, 2025.
The ability to edit the very code of life, DNA, is no longer science fiction. With technologies like CRISPR, scientists have a powerful tool to alter genes with increasing precision. This has opened the door to incredible therapeutic possibilities, but it has also brought us to a profound ethical crossroads: Should we use this power to edit the genes of our children in ways that can be passed down through generations?
This question was thrust into the global spotlight in 2018 when Chinese scientist He Jiankui announced he had created the world’s first gene-edited babies. The act was widely condemned, but it proved that heritable human germline editing was possible. Recently, major scientific organizations called for a 10-year moratorium on the practice, arguing we “simply lack the tools to make it safe now.”
But is safety the only barrier? And if we overcome it, what other ethical hurdles must we navigate? A recent Gizmodo article gathered insights from leading bioethicists to explore this complex territory.
The Line Between Treatment and Enhancement
At the heart of the debate is the distinction between “somatic” and “germline” editing.
Somatic editing targets body cells to treat a disease in a single person. These changes are not inherited. This is already happening today, with groundbreaking FDA-approved CRISPR therapies freeing children from the symptoms of sickle cell disease.
Germline editing targets reproductive cells (eggs, sperm, embryos). These changes are heritable, meaning they are passed down to all future generations.
While many draw a hard line between the two, bioethicist Marsha Michie notes that the boundary can be blurry. Fetal gene editing or even somatic treatments could have unintended “off-target” effects on reproductive cells.
The Arguments for Moving Forward (With Caution)
Bioethicist James J. Hughes argues that calls for a permanent ban are rooted in fear, not facts, comparing them to past moral panics over IVF and birth control. He contends that true reproductive liberty includes the right to use the best available science to ensure a child’s health. The focus, he argues, should be on robust regulation by existing bodies like the FDA, not a blanket prohibition.
The specter of eugenics is often raised, but Hughes flips the argument: “If eugenics means state control over reproduction, then the lesson of the 20th century is to defend reproductive freedom, not curtail it.”
The Case for Hitting the Brakes
The primary concern, echoed by all experts, is safety. As bioethicist Kerry Bowman warns, “We don’t know what we don’t know.” Making permanent, inheritable changes without fully understanding the long-term consequences is a monumental risk.
Beyond safety, other profound ethical questions loom:
Justice and Access: As ethicist Arthur Caplan points out, if creating “better” kids is expensive, will it create a new class system of the genetically enhanced and the natural-born? Fairness in access, he notes, has historically never stopped a technology that the wealthy want.
Defining “Improvement”: Who decides what traits are worth enhancing? While eliminating diseases like Huntington’s seems straightforward, what about deafness, which many in the deaf community view as a culture, not a disability to be “cured”? Caplan warns against parents making choices that narrow, rather than expand, a child’s future.
Global Regulation: Even with a moratorium in Western nations, what stops researchers from setting up shop in countries with lax regulations? Bowman expresses skepticism that a ban could be effectively enforced globally, especially when market forces are a primary driver of new technology.
A Future in the Balance
The consensus among the experts is clear on one thing: We are not ready for heritable germline editing today. The tools are too crude, the risks too high. The proposed 10-year ban reflects this caution.
But as Arthur Caplan predicts, “Yes, we will see genetic modification of our children. It will come.” The debate we have now will shape the world our descendants inherit—a world where humanity may have the power to direct its own evolution. For more information on the science, you can explore the National Human Genome Research Institute.
(Read more about our technology and ethics analysis at ICAEPA
This complex issue requires a broad public conversation. We want to hear your perspective.
Where should society draw the line between treating a disease and enhancing a human?
Who do you trust to regulate this powerful technology—scientists, national governments, or an international body?
If gene editing were proven to be safe, would you consider it for your future children to prevent a serious disease?
Join the discussion and share your thoughts in the comments section below.